Revvity
ActiveSummary
Revvity has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.5m and a net result of -€510,812. Equity is shrinking by ~6% per year across the filed fiscal years. Its solvency ranks better than 62% of 8281 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 71 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
History
On 30 April 1997, Revvity was incorporated.1 A capital increase in 2015 brought the capital to EUR 8.6 million.2 The registered office moved to Mechelen in 2019 and to Lier in 2023.34 Since 2023 the company has been called Revvity.5 MAGGIONI Massimo has served as director of the company since 2023.5 Revenue went from EUR 4.7 million in 2018 to EUR 1.8 million in 2024 and headcount from 72.6 full-time equivalents in 2018 to 28.4 in 2025.6
Go further with this company
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Peer companies
Historical observationOf the 8,612 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 94% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a small loss
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 8,612 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €11.4m | €12.9m | €6.2m | €7.1m | - | - |
| Turnover70 | €5.4m | €4.7m | €915,409 | €1.8m | - | - |
| Other operating income74 | €6.0m | €8.2m | €5.3m | €5.3m | - | - |
| Operating charges60/66A | €9.1m | €11.8m | €7.2m | €6.5m | - | - |
| Services and other goods61 | €1.8m | €3.6m | €1.5m | €1.6m | - | - |
| Remuneration, social security and pensions62 | €7.1m | €7.9m | €5.6m | €4.8m | €5.1m | ▲ 5.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,205 | €0 | - | - | - | - |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | - | - | €250,000 | - |
| Other operating charges640/8 | €161,119 | €209,210 | €105,932 | €50,653 | €297,404 | ▲ 487% |
| Non-recurring operating charges66A | €7,274 | €71,451 | €5,737 | €11,251 | €4,266 | ▼ 62.1% |
| Gross operating margin9900 | - | - | - | - | €5.4m | - |
| Operating profit (loss)9901 | €2.3m | €1.1m | -€1.0m | €609,357 | -€324,779 | ▼ 153% |
| Financial income75/76B | - | - | €152,374 | €131,589 | €91,854 | ▼ 30.2% |
| Recurring financial income75 | €14,388 | €32,535 | €152,374 | €131,589 | €91,854 | ▼ 30.2% |
| Other financial income752/9 | €14,388 | €32,535 | €152,374 | €131,589 | - | - |
| Financial charges65/66B | €20,645 | €25,079 | €17,263 | €15,981 | €21,569 | ▲ 35.0% |
| Recurring financial charges65 | €20,645 | €25,079 | €17,263 | €15,981 | €21,569 | ▲ 35.0% |
| Other financial charges652/9 | €20,645 | €25,079 | €17,263 | €15,981 | - | - |
| Profit (loss) for the period before taxes9903 | €2.3m | €1.1m | -€868,912 | €724,965 | -€254,494 | ▼ 135% |
| Income taxes67/77 | €658,671 | €373,034 | €122,961 | -€100,536 | €256,318 | ▲ 355% |
| Taxes670/3 | €658,671 | €373,034 | €122,961 | €16,071 | - | - |
| Tax adjustments and reversals of tax provisions77 | - | - | - | €116,607 | - | - |
| Profit (loss) for the period9904 | €1.7m | €772,497 | -€991,873 | €825,500 | -€510,812 | ▼ 162% |
| Profit (loss) for the period to be appropriated9905 | €1.7m | €772,497 | -€991,873 | €825,500 | -€510,812 | ▼ 162% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €12.7m | €7.5m | €5.7m | €5.8m | €6.2m | ▲ 6.3% |
| Fixed assets21/28 | €218,055 | €198,565 | €177,357 | €160,634 | €137,567 | ▼ 14.4% |
| Tangible fixed assets22/27 | - | - | - | - | €3,553 | - |
| Plant, machinery and equipment23 | - | - | - | - | €3,553 | - |
| Financial fixed assets28 | €218,055 | €198,565 | €177,357 | €160,634 | €134,014 | ▼ 16.6% |
| Other financial fixed assets284/8 | €218,055 | €198,565 | €177,357 | €160,634 | - | - |
| Amounts receivable and cash guarantees285/8 | €218,055 | €198,565 | €177,357 | €160,634 | - | - |
| Current assets29/58 | €12.5m | €7.3m | €5.5m | €5.7m | €6.0m | ▲ 6.9% |
| Amounts receivable within one year40/41 | €12.4m | €7.2m | €5.3m | €5.6m | €6.0m | ▲ 6.9% |
| Trade receivables40 | €1.1m | €2.0m | €2.4m | €800,917 | €921,599 | ▲ 15.1% |
| Other amounts receivable41 | €11.3m | €5.2m | €2.9m | €4.8m | €5.1m | ▲ 5.5% |
| Cash at bank and in hand54/58 | €18,199 | €106,194 | €4,703 | - | - | - |
| Deferred charges and accrued income490/1 | €36,455 | €62,763 | €245,032 | €12,051 | €15,686 | ▲ 30.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €12.7m | €7.5m | €5.7m | €5.8m | €6.2m | ▲ 6.3% |
| Equity10/15 | €9.4m | €4.1m | €3.1m | €4.0m | €3.5m | ▼ 12.9% |
| Contributions10/11 | €2.1m | €2.1m | €2.1m | €2.1m | €2.1m | = |
| Reserves13 | €220,996 | €220,996 | €220,996 | €220,996 | €220,996 | = |
| Non-distributable reserves130/1 | €220,996 | €220,996 | €220,996 | €220,996 | €220,996 | = |
| Reserves not available under the articles1311 | €220,996 | €220,996 | €220,996 | €220,996 | €220,996 | = |
| Profit (loss) carried forward14 | €7.1m | €1.9m | €867,730 | €1.7m | €1.2m | ▼ 30.2% |
| Provisions and deferred taxes16 | - | - | - | - | €250,000 | - |
| Provisions for liabilities and charges160/5 | - | - | - | - | €250,000 | - |
| Other liabilities and charges164/5 | - | - | - | - | €250,000 | - |
| Amounts payable17/49 | €3.3m | €3.4m | €2.6m | €1.9m | €2.5m | ▲ 33.9% |
| Amounts payable within one year42/48 | €3.3m | €3.4m | €2.6m | €1.9m | €2.5m | ▲ 33.9% |
| Trade debts44 | €1.4m | €1.5m | €1.3m | €767,290 | €1.0m | ▲ 35.5% |
| Suppliers440/4 | €1.4m | €1.5m | €1.3m | €767,290 | €1.0m | ▲ 35.5% |
| Taxes, remuneration and social security45 | €1.9m | €1.9m | €1.3m | €1.1m | €1.4m | ▲ 33.5% |
| Taxes450/3 | €627,235 | €747,850 | €392,554 | €241,280 | €427,340 | ▲ 77.1% |
| Remuneration and social security454/9 | €1.3m | €1.2m | €861,949 | €837,684 | €1.0m | ▲ 20.9% |
| Other amounts payable47/48 | - | - | - | €4,882 | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €1.7m | €772,497 | -€991,873 | €825,500 | -€510,812 | ▼ 162% |
| + Depreciation and write-downs630 | €1,205 | €0 | - | - | - | - |
| Operating cash flow (approximation) | €1.7m | €772,497 | -€991,873 | €825,500 | -€510,812 | ▼ 162% |
| Investment in fixed assets (approximation) | - | €19,490 | €21,208 | €16,723 | €23,067 | ▲ 37.9% |
| Change in cash | - | €87,995 | -€101,491 | - | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
17-12
State Gazette act
Appointment: Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV (statutory auditor)Permanent representative: Koen Neijens · Mandate term4 facts ▸
- General meeting, 13-02-2025
- Auditor appointment, Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV (statutory auditor)
- Permanent representative, Koen Neijens
- Mandate term, 3 years, ending immediately after the ordinary general meeting approving the accounts for the year ended 31 December 2026
18-09
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
- Board meeting, 08-09-2025
- Power of attorney, Bob Van Der Jeugt
05-03
State Gazette act
Resignations & appointmentsPower of attorney3 facts ▸
- Board meeting, 22-02-2024
- Power of attorney, Chantelle Diana Vermaak
- Power of attorney, Ann Van Buynder
09-02
State Gazette act
MiscellaneousPower of attorney · Ratification · Power of attorney restriction5 facts ▸
- Board meeting, 07-03-2023
- Power of attorney, Velina Vercaigne
- Power of attorney, Yvonne Simone Rowlands-Roelfsema
- Ratification, Goedkeuring, bevestiging en bekrachtiging van alle handelingen door Velina Vercaigne sinds 1 januari 2023 en door Yvonne Rowlands-Roelfsema sinds januari 2023 d…
- Power of attorney restriction, Niet gemachtigd om contracten te ondertekenen met zichzelf, haar partner, een familielid of een partij waarmee ze een financieel of ander belang heeft
18-07
State Gazette act
Registered officeRegistered-office move · Power of attorney3 facts ▸
- Board meeting, 29-06-2023
- Registered-office move, Duwijckstraat 17, 2500 Lier
- Power of attorney, Eubelius CVBA
20-06
State Gazette act
Reappointment: MAGGIONI Massimo (director)Reserve release · Name change · Statutes amendment7 facts ▸
- General meeting, 07-06-2023
- Reserve release, Omvorming van statutair onbeschikbare eigen vermogensrekening in beschikbare eigen vermogensrekening
- Name change, Revvity
- Statutes amendment
- Capital
- Director reappointment, MAGGIONI Massimo (director)
- Mandate compensation, MAGGIONI Massimo
Show earlier events
24-12
State Gazette act
Registered officeRegistered-office move2 facts ▸
- Board meeting, 25-11-2019
- Registered-office move, Kardinaal Mercierplein 2, 2800 Mechelen
07-03
State Gazette act
Resignation: A.J. Crook (manager)Appointment: M. Maggioni (manager) · Power of attorney · Mandate compensation6 facts ▸
- General meeting, 02-11-2018
- Power of attorney, Isabella Maria Wouters
- Power of attorney, Chantelle Diana Vermaak
- Director resignation, A.J. Crook (manager)
- Director appointment, M. Maggioni (manager)
- Mandate compensation, M. Maggioni
31-08
State Gazette act
Resignation: Erwin Van den Bogaert (manager)Appointment: Isa Wouters (manager) · Mandate compensation4 facts ▸
- General meeting, 09-04-2018
- Director resignation, Erwin Van den Bogaert (manager)
- Director appointment, Isa Wouters (manager)
- Mandate compensation, Isa Wouters
10-10
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
- Board meeting, 30-06-2017
- Power of attorney, Velina Vercaigne
14-02
State Gazette act
Resignations & appointmentsPower of attorney3 facts ▸
- General meeting, 30-11-2016
- Power of attorney, Nico Verlinden (bijzonder gevolmachtigde)
- Power of attorney, Hans Tonen
18-12
State Gazette act
Appointment: PerkinElmer (director)Power of attorney · Conversion6 facts ▸
- Board meeting, 18-11-2015
- Power of attorney, Erwin Van den Bogaert
- Power of attorney, Anja Ceuppens
- Power of attorney, Philip Comet
- Conversion, BVBA (2015-11-30)
- Director appointment, PerkinElmer
17-12
State Gazette act
Resignations: VAN DEN BOGAERT Erwin Lydie Leonard, CROOK Andrew John and HEALY John LeoAppointments: VAN DEN BOGAERT Erwin Lydie Leonard, CROOK Andrew John and HEALY John Leo · Reappointment: Mazars Bedrijfsrevisoren (statutory auditor) · Capital increase18 facts ▸
- General meeting, 30-11-2015
- Capital increase, €8.500.000
- Bank account, BE61 3631 5500 3717
- Capital decrease, €6.511.360,86
- Legal-form conversion, besloten vennootschap met beperkte aansprakelijkheid
- Capital, €2.050.639,14
- Director resignation, VAN DEN BOGAERT Erwin Lydie Leonard (director)
- Director resignation, CROOK Andrew John (director)
- Director resignation, HEALY John Leo (director)
- Director appointment, VAN DEN BOGAERT Erwin Lydie Leonard (niet statutair zaakvoerder)
- Director appointment, CROOK Andrew John (niet statutair zaakvoerder)
- Director appointment, HEALY John Leo (niet statutair zaakvoerder)
- +6 further facts in this act
24-02
State Gazette act
Resignation: Pierre-Michel Herzet (director)Appointment: Andrew John Crook (director) · Reappointments: John Healy (director) and Erwin Van den Bogaert (managing director) · Mandate compensation7 facts ▸
- General meeting, 31-12-2013
- Director resignation, Pierre-Michel Herzet (director)
- Director appointment, Andrew John Crook (director)
- Mandate compensation, Andrew John Crook
- Director reappointment, John Healy (director)
- Director reappointment, Erwin Van den Bogaert (managing director)
- Power of attorney, Hans Toonen
04-01
State Gazette act
Resignation: Deloitte Bedrijfsrevisoren BV in de vorm van een coöperatieve vennootschap (commissaris revisor)Appointment: Mazars Bedrijfsrevisoren CVBA (commissaris revisor)3 facts ▸
- General meeting, 30-11-2012
- Director resignation, Deloitte Bedrijfsrevisoren BV in de vorm van een coöperatieve vennootschap (commissaris revisor)
- Director appointment, Mazars Bedrijfsrevisoren CVBA (commissaris revisor)
11-02
State Gazette act
Resignation: Erik Smet (director)2 facts ▸
- General meeting, 30-11-2010
- Director resignation, Erik Smet (director)
09-12
State Gazette act
Resignation: Alberto Chiaravallotti (director)2 facts ▸
- General meeting, 01-08-2010
- Director resignation, Alberto Chiaravallotti (director)
27-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)Auditor mandate expiry3 facts ▸
- General meeting, 11-05-2010
- Auditor reappointment, Deloitte Bedrijfsrevisoren
- Auditor mandate expiry, 12-05-2010
06-10
State Gazette act
Resignation: Robosa Gbinoba (human resources leader benelux)Power of attorney · Mandate term · Mandate restriction7 facts ▸
- General meeting, 18-08-2008
- Director resignation, Robosa Gbinoba (human resources leader benelux)
- Power of attorney, Robosa Gbinoba
- Power of attorney, Anja Ceuppens
- Mandate term, zolang zij de functie van "HR leader Belgium" bij PERKINELMER nv uitoefent
- Mandate restriction, niet gemachtigd om contracten te ondertekenen met zichzelf / echtgenoot / familielid / of met welke partij waarmee ze een financieel of ander belang heeft
- Mandate revocation, de raad van bestuur behoudt zich het recht voor om deze bevoegdheid op eender welk ogenblik en om eender welke reden in te trekken
20-06
State Gazette act
Resignation: Yves Moens (director)Appointment: Erwin Van den Bogaert (director) · Mandate compensation4 facts ▸
- General meeting, 15-04-2004
- Director resignation, Yves Moens (director)
- Director appointment, Erwin Van den Bogaert (director)
- Mandate compensation, Erwin Van den Bogaert
14-03
State Gazette act
Resignations: Giuseppe Fusar Poli, Jack Healy and Bruno VaesReappointments: Jack Healy (director) and Bruno Vaes (director) · Appointments: Yves Moens, Erik Smet and Bruno Vaes · Mandate compensation10 facts ▸
- General meeting, 12-05-2004
- Director resignation, Giuseppe Fusar Poli (director)
- Director resignation, Jack Healy (director)
- Director resignation, Bruno Vaes (director)
- Director reappointment, Jack Healy (director)
- Director reappointment, Bruno Vaes (director)
- Director appointment, Yves Moens (director)
- Director appointment, Erik Smet (director)
- Mandate compensation, PERKINELMER
- Director appointment, Bruno Vaes (managing director)
Directors · office · real estate
Board 1
6 not recently confirmed
Day-to-day management 1
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12392A0300/00C000 | Flanders | 5.6 ha | 1 · 2.3 ha | 20.8 m · 3 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- Other function
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| MAGGIONI Massimo |
|
| Bruno Vaes |
|
| Jack Healy |
|
| CROOK Andrew John |
|
| HEALY John Leo |
|
| Isa Wouters |
|
| M. Maggioni |
|
| A.J. Crook |
|
| VAN DEN BOGAERT Erwin Lydie Leonard |
|
| Mazars Bedrijfsrevisoren |
|
| Pierre-Michel Herzet |
|
| Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises |
|
| Erik Smet |
|
| Alberto Chiaravallotti |
|
| Robosa Gbinoba |
|
| Yves Moens |
|
| Giuseppe Fusar Poli |
|
Articles of association
Full purpose
De research, ontwikkeling, productie, marketing en verkoop op wereldvlak van (1) scheikundige en biologische testproducten en verwante diensten en toepassingen voor gebruik in biowetenschappelijke research (met inbegrip van, zonder beperking, hoge verwerkingsscreening als een researchwerktuig voor farmaceutische ontwikkeling), en in vitro diagnoseproducten in open systemen, en (2) radioactief gekwalificeerde reagentia voor toepassing binnen of buiten research inzake gezondheidszorg en biowetenschappelijke research.
Structure & network
Owners and holdings
2 ownersOwners 2
- Revvity Life Sciences International Holdings LtdGBparentSourceown accounts 202599%
- Revvity Inc.USSourceown accounts 20251%
Holdings 0
The accounts to 31-12-2025 list no holdings, and no other source names one.
According to the 2025 annual accounts of Revvity and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
Capital and shareholders
- Perkinelmer Life Sciences International Holdings (BE 0643.475.036)
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 20-06-2023 Capital stated in the act · 345,241 shares
- 17-12-2015 Capital increase of 8,500,000 EUR · to 8,562,000 EUR · 342,741 new shares
- 17-12-2015 Capital reduction of 6,511,360.86 EUR · to 2,050,639.14 EUR · “aanzuivering van geleden verliezen”
Subsidies and aid
European Union, budget
2024 · 1 entry · 152,887 EUR in total| Year | Entries | awarded |
|---|---|---|
| 2024 | 1 | 152,887 EUR |
Recognitions · licences · registrations
Food safety, FASFC
1 siteSimilar companies · same sector, comparable size
Company details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.